One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
AI-powered journal recommender
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
https://doi.org/10.1016/j.esmoop.2025.105053
Copy DOI
Save
Chat PDFNEW
Export
Cite
Share
Translate Chat PDFNEWCiteExportShare Journal: ESMO open |  Publication Date: May 1, 2025 |
Affiliation: Deutschen Konsortium für Translationale Krebsforschung, National and Kapodistrian University of Athens, Military Medical Academy, University Dermatology, University Hospital Leipzig, University Hospital Schleswig-Holstein, University Hospital Würzburg, Helios Klinikum Erfurt, Laiko General Hospital of Athens, University of Tübingen, Ruhr University Bochum, Aix-Marseille Université, Charité - Universitätsmedizin Berlin, University Medical Centre Mannheim, University of Trier, Statistisches Bundesamt
Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
